cervical cancer

A equipa liderada por Olga Martinho e Rui Manuel Reis, do Instituto de Investigação em Ciências da Vida e Saúde (ICVS) da Universidade do Minho, em colaboração com várias instituições brasileiras, focou este estudo na procura de novas e melhores abordagens terapêuticas para o cancro do colo do útero.

Crowne Plaza Barcelona, Barcelona, Spain

22- 23 January 2016

See more informations here: http://www.primeoncology.org/live-education/solid-tumor/gyn-congress-2016/

Crowne Plaza Barcelona, Barcelona, Spain

22- 23 January 2016

See more informations here: http://www.primeoncology.org/live-education/solid-tumor/gyn-congress-2016/

Authors and Affiliations:

Joana Ribeiro,^1,2,3 Joana Marinho Dias,^1,2,4 Paula Monteiro,⁵ Joana Loureiro,⁵ Inês Baldaque,¹ Rui Medeiros,^1,2,4,6 and Hugo Sousa ^1,2

¹ Virology Service, Portuguese Institute of Oncology of Porto, Portugal

² Molecular Oncology and Viral Pathology Group (CI-IPOP), Portuguese Institute of Oncology of Porto

Authors and affiliations:

Stephanie Anais Castaldo ^1,2, Alda Pereira da Silva ¹, Andreia Matos ¹, Ângela Inácio ^1,3, Manuel Bicho ^1,3, Rui Medeiros ⁴, Irina Alho ⁵, Maria Clara Bicho ^{1, 2}

¹ Genetics Laboratory and Environmental Health Institute, Faculty of Medicine, University of Lisbon, Portugal

Authors and affiliations:
Mariana Oliveira, Bárbara Peleteiro, Nuno Lunet

During the development of the PhD thesis in Biology in prevention strategies and study potential markers for the development of cancer of the cervix, performed at the National Institute of Health Dr. Ricardo Jorge, IP Lisbon, Ana Gradíssimo collected data suggesting that the determination of the physical state of the DNA of human papillomavirus (HPV) may be a marker of progression and/or development of premalignant lesions of this tumor.